Join UK-CAB to shape the future of HIV care.
ukcab.net/about/join/
If you are attending to #BHIVABASHH26 in Liverpool, come and visit us in the exhibition hall!
@Positively_UK @angelina_namiba
@HarunTulunay @NAT_AIDS_Trust @BritishHIVAssoc @BASHH_UK @4Mproject
The HIV Action Plan has promise — but real progress needs action and accountability.
Prisons, women, trans people + marginalised groups must not be left behind.
You can read our public statement regarding to new HIV Action Plan below.
Recent claims linking autism to Tylenol/vaccines are not supported by science.
We stand against misinformation that fuels stigma, fear, and distrust in healthcare. Our community values evidence-based information, respect for lived experience, and the right to safe, informed care.
WHO statement on autism-related issues
The World Health Organization (WHO) emphasizes that there is currently no conclusive scientific evidence confirming a possible link between autism and use of acetaminophen (also known as paracetamol) during pregnancy.
Globally, nearly 62 million people (1 in 127) have autism spectrum disorder, a diverse group of conditions related to development of the brain. Although awareness and diagnosis have improved in recent years, the exact causes of #autism have not been established, and it is understood there are multiple factors that can be involved.
Extensive research has been undertaken over the past decade, including large-scale studies, looking into links between acetaminophen use during pregnancy and autism. At this time, no consistent association has been established.
WHO recommends that all women continue to follow advice of their doctors or health workers, who can help assess individual circumstances and recommend necessary medicines.
Any medicine should be used with caution during pregnancy, especially in the first three months, and in line with advice from health professionals.
Also, a robust, extensive evidence base exists showing childhood vaccines do not cause autism. Large, high-quality studies from many countries have all reached the same conclusion. Original studies suggesting a link were flawed and have been discredited.
Since 1999, independent experts advising WHO have repeatedly confirmed that vaccines - including those with thiomersal or aluminum - do not cause autism or other developmental disorders.
Childhood vaccine schedules are developed through a careful, extensive and evidence-based process involving global experts and country input.
The childhood immunization schedule, carefully guided by WHO, has been adopted by all countries, and has saved at least 154 million lives over the past 50 years. The schedule remains essential for the health and wellbeing of every child and every community. These schedules have continually evolved with science and now safeguard children, adolescents and adults against 30 infectious diseases.
Every vaccine recommendation by the Strategic Advisory Group of Experts on Immunization (SAGE), an independent advisory group to WHO, is grounded in rigorous review of evidence and carefully designed to offer the best protection against serious diseases and to be delivered when most needed.
When immunization schedules are delayed or disrupted, or altered without evidence review, there is a sharp increase in the risk of infection not only for the child, but also for the wider community.
Infants too young to be vaccinated and people with weakened immune systems or underlying health conditions are at greatest risk.
Autism and neurodevelopmental disorders are among priority mental health and neurological conditions being discussed at the 4th UN High-Level Meeting on NCDs and mental health this Thursday, 25 September.
As a global community, we need to do more to understand the causes of autism and how best to care for and support the needs of autistic people and their families.
WHO is committed to advancing this goal working together with partners including autistic-led organizations and other organizations representing persons with lived experience.
WHO also stands with people who are living with autism and their families, a dignified community entitled to evidence-based considerations free of stigma.
Full statement: bit.ly/47YsgwI
We encourage all people living with HIV in Europe to join this short study run by @ShareEastLondon team to share their experiences with new HIV treatments and their conversations with their clinical team about their treatment choices.
Please visit the page & complete the survey.
Our latest study 'ASK US Europe' is live and open to recruitment for people living with HIV in Europe who are on ART!
Please share widely across your networks in Europe and the UK.
👇🏽👇🏽👇🏽
bit.ly/4m5ktRm
/1
1
122
🚨 @GileadSciences lenacapavir could be a game-changer for #HIV -but at $28K/year, it’s priced out of reach for most. Generics could cost <$50.
We’re calling on @GileadHIV to make it affordable for all, not just the privileged few.
Please find UK-CAB public response below.
After a long time and problems with X support, we are back!
However, if you would like to follow us on BlueSky, you can find us here:
bsky.app/profile/ukcab.bsky.…
55
We're having a fantastic time at #BHIVA24 - find out what we've been up to as a network and visit us in the exhibition space 😊 – at Birmingham, England
A high proportion of older people with HIV are taking medicines they do not need that could increase the risk of falls and confusion, Spanish researchers have found in a review of studies looking at inappropriate medication prescribing in people with HIV. aidsmap.com/news/feb-2024/to…
Huge thanks to the i-Base team, in particular Simon Collins for all the hard work that has gone into HTB.
It has been an incredible resource which is accessible to the community, engages clinicians and has shared the amazing progress of HIV treatment for more than two decades!
HTB Dec 2023/Jan 2024 is now available.
After publishing HTB for 24 years, this is not just the last issue this year, but also the last in this format. With news from @EACSociety, the Ageing Workshop & More.
Editorial.
i-base.info/htb/46762
@BritishHIVAssoc
@ukcab
@NHIVNA
Wonderful to chat with @londonpatient today when he dropped by the @HIViBase office.
Your story continues to give us hope that one day a cure will be achievable for everyone living with HIV.
Listen up! Young people living with HIV have something to say!
@ChivaProjects has been collecting their stories for a new podcast. Health professionals and experts then discuss the issues raised.
Listen to the six-part series, Positive Advice: audioboom.com/channels/51016…
1
100
Find out more about the history and current work of UK-CAB next Tuesday, followed by a look at HIV and mental health on Tues 4 July.
Previous modules covering everything from the history of HIV in the UK, to HIV treatment, prevention and cure now online
ukcab.net/training/
Thanks to everyone who attended our community workshop today during #BHIVA23 - great discussions on the myths around HIV medication!
It's easy to forget that many people still have a lot of questions about the pills they are taking on a daily basis.
Really useful updates on latest HIV and STI treatment and prevention from #CROI2023 ⤵️
📣 @BritishHIVAssoc "Best of CROI 2023" recorded webinars are now available to access on the website!
Click here to watch 👉 bhiva.org/BestofCROI2023
Webinar this Wednesday afternoon (UK) "Why Viral Load Can Be Detectable Despite Perfect Adherence" - register via link below
Places still available to register. Details👇🏿
treatmentactiongroup.org/web…
@ukcab
@afrocab_hiv
@SophiaForum
@commsbizchat
@4Mproject
@GeorgeHouseTrst
@PositiveEast
@Positively_UK
@janesheps
@MindfulHIV
@ChivaProjects
@BritishHIVAssoc
@NHIVNA
Great to be with our community today, stigma creates barriers to testing, and leads to problems starting treatment and accessing care #FightHIVstigma
Spring booster COVID vaccine available for all people living with HIV, more info in the thread below ⤵️
BHIVA Statement on JCVI recommendations for COVID vaccine Spring 2023 booster dose for people living with HIV 👇
tinyurl.com/draxk4ja
178


























